Low Evidence
Research Overview
5-Amino-1MQ Research for Fatty Liver (NAFLD)
An evidence-based overview of research examining 5-Amino-1MQ in the context of fatty liver (nafld). This page synthesizes findings from peer-reviewed literature.
Research Summary
Liver-specific NNMT knockdown reduced hepatic steatosis in mice via Sirt1 activation. 5-Amino-1MQ's effects on liver specifically have not been extensively characterized, and systemic NNMT inhibition may affect multiple tissues.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. 5-Amino-1MQ has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.